Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01654614
Other study ID # 62/18.07.2012
Secondary ID
Status Completed
Phase N/A
First received July 22, 2012
Last updated January 14, 2017
Start date November 2011
Est. completion date July 2012

Study information

Verified date January 2017
Source Democritus University of Thrace
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Primary objective of this study was to evaluate the diagnostic capability of keratoconus match index (KMI) and keratoconus match probability (KMP) indexes in forme fruste keratoconus (FFK), and their association with a series of Pentacam-derived keratconus (KC) indexes. KMI and KMP parameters are KC-specifc indexes that are measured by Ocular Response Analyzer (ORA), based on the distinct ORA-derived waveform characteristics of KC eyes.

Study participants were recruited from the Cornea Outpatient service in a consecutive if eligible basis. Two study groups were formed: a) FFK group (FFKG) that included patients diagnosed with FFK, and, b) Control group (CG) was formed by refractive surgery candidates.

All ORA (Reichert Ophthalmic Instrument, Buffalo, NY, USA, software version: 3.01)and Pentacam (Pentacam HR, Oculus Optikgerate GmbH, Heidelberg, Germany)measurements were performed by the same experienced operator in a consistent way


Recruitment information / eligibility

Status Completed
Enrollment 120
Est. completion date July 2012
Est. primary completion date June 2012
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- diagnosis of keratoconus KC in the fellow eye according to the Amsler-Krumleich criteria (FFKG)

- KISA index between 60 and 100% in the FFK eye (FFKG)

- lack of any KC-related findings / signs in the slit-lamp biomicroscopy (FFKG)

- uneventful ophthalmologic history (CG)

- no indications of corneal pathology in slit-lamp biomicroscopy and Placido disk-based videokeratography (CG)

- KISA index value less than 60% (CG)

Exclusion Criteria:

for both study groups:

- previous incisional eye surgery

- corneal scars and opacities

- history of herpetic keratitis, severe eye dryness

- pregnancy or nursing

- current corneal infection

- glaucoma

- suspicion for glaucoma

- IOP lowering treatment

- underlying autoimmune disease

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Greece Eye Institute of Thrace (???) Alexandroupolis Evros

Sponsors (1)

Lead Sponsor Collaborator
Democritus University of Thrace

Country where clinical trial is conducted

Greece, 

References & Publications (1)

Labiris G, Giarmoukakis A, Gatzioufas Z, Sideroudi H, Kozobolis V, Seitz B. Diagnostic capacity of the keratoconus match index and keratoconus match probability in subclinical keratoconus. J Cataract Refract Surg. 2014 Jun;40(6):999-1005. doi: 10.1016/j.j — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Keratoconus Match Index (KMI) KMI is the outcome of a neural network calculation of seven ORA-derived waveform scores and represents the similarity of the waveform of the examined eye against the same average waveform scores of the keratoconus eyes in the machine's database.
Receiver operating characteristics (ROC) curves were applied to determine the overall predictive accuracy of KMI parameter,as described by the area under the curve (AUC), in differentiating FFK cases from normal ones. The impact of Pentacam-derived KC related indexes on KMI was assessed with stepwise forward multivariate regression analysis.
one day